Shaping the future with our Supply Chain to Patient Strategic Framework

29 October 2023
Supply Chain to Patient
Scott Clayton
Phorum Director

The biopharmaceutical industry is crucial in delivering life-saving medications, vaccines, and therapies to patients worldwide. However, recent challenges—such as the COVID-19 pandemic and geopolitical events like the war in Ukraine—have highlighted the necessity for the outbound supply chain to transform into a more agile, robust, and cost-effective system that caters to the needs of patients.

A well-functioning outbound biopharmaceutical supply chain is critically important to industry as delays, shortages, and inefficiencies cause disruption to the availability of essential medications and compromise patient care. While other industry supply chains have successfully embraced digitalization, agility and customer-centricity, the pharmaceutical supply chain has lagged.

“As modalities become more complex, we must develop strategies to manage new handling characteristics (e.g., deep frozen, cytotoxic ADCs, autologous treatment, etc.) while simultaneously abiding by all regulations and minimizing our environmental impacts,” said Rich Whiteman, Associate Director of Clinical Supply Chain Strategy & Innovation at Janssen. “This demands an evolved clinical supply chain which is more nimble, adaptable, and sustainable.”

To drive change within industry, it is now more important than ever to collaborate, identify the key challenges, and understand what a future supply chain would require to be successful for the ultimate benefit of patients worldwide.

This is why we have published A visionary Strategic Framework for future patient-centric outbound biopharmaceutical supply chains.

The Framework is a reference for the biopharmaceutical industry, enabling organizations to align with industry trends, reassess their priorities, and plan future developments. Our Supply Chain to Patient Phorum will use the Framework objectives to evaluate its program and ensure alignment with industry goals, fostering focused collaboration.

The Framework focuses on five strategic objectives:

  1. Data-driven decision-making: fully digital integrated supply chain enabled by accurate real-time information
  2. Uninterrupted, cost-effective, agile supply chain: ensuring continuity of supply in an adaptable and cost-effective manner
  3. Sustainable and responsible: sustainable supply chain with minimized impact on the planet
  4. Dynamic and skilled workforce: diverse workforce supported by ongoing training and development opportunities
  5. Drive innovation through collaboration: engaging with regulators, healthcare and patients to drive innovation and industry collaboration.

“The Supply Chain to Patient Strategic Framework aims to enhance the efficiency and visibility of healthcare supply chains,” said Craig Embleton, Executive Director of Global Logistics CSC, Bristol Myers Squibb.” This will ensure that essential medical products reach patients in a timely manner, ultimately improving patient care and outcomes.”

The Framework targets the outbound biopharmaceutical supply chain. Established organizations can align their existing frameworks with industry standards while emerging ones can adopt or directly customize the Framework.

It can be used by the leaders and managers of a range of organizations in industry—including biomanufacturers and cell and gene therapy companies and partners such as logistic organizations, technology providers, clinical research organizations, and contract development and manufacturing organizations. These can gain insights into biopharmaceutical supply chain needs and align their offerings accordingly.

By having a framework that is open and transparent about industry goals, organizations can communicate their aligned direction and intentions to all associated suppliers and partners, which in turn will allow understanding and promote collaboration with suppliers and key stakeholders. Within organizations, the Framework can be used by leaders in different departments, such as global supply chain, global strategic sourcing, business and operational excellence, product development, product management and procurement.

This Framework is the first deliverable of a multi-part project and will be accompanied by a maturity model that will be aligned with the strategic objectives in the Framework. The maturity model will allow biopharmaceutical organizations to assess their maturity level in each area and enable industry benchmarking.

For more information, download the paper here and contact Scott Clayton, Account Manager, at

Sustainabilty Lightbulb
How are you improving your environmental sustainability performance?
BioPhorum Introduces – Sustainability in conversation with Ipsen
Digital face, data
On your marks, get set, go! How to start your data governance project
BioPhorum introduces – A sustainable supply chain to patient
Data Integrity Words On Dark Background
Tackling the five crucial data integrity challenges in QC labs

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.


BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.


Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.


Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Inaugural BioPhorum Quality face to face – get involved
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
Delivering a Cell and Gene Therapy Outbound Supply Chain Pathway for the Industry
DNA and Earth on blue background
A vision for the biopharmaceutical industry’s inbound supply chain
A major milestone – a harmonized approach to product carbon footprint data
Technology Roadmap V 2.0
BioPhorum Technology Roadmapping roadmap vision 2.0


Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.


Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.


BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.


A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Bioreactivity testing in single-use system biomanufacturing